Surescripts, the nation’s leading health information network, announced that TPG will join the ownership group as a majority investor. And TPG is investing in Surescripts through TPG Capital, the firm’s U.S. and European private equity platform.
TPG’s investment will enable Surescripts to develop various solutions addressing healthcare’s biggest challenges. And this investment will accelerate Surescripts’ ability to scale existing Intelligent Prescribing, Benefits and Authorizations, and Clinical Interoperability solutions. Plus, it will enable Surescripts to streamline the benefits process further to reduce clinician burnout, help prescribers more efficiently deliver affordable medications to patients, and support the role of pharmacists as part of an evolving care team.
TPG has experience supporting leading U.S. healthcare organizations across the industry. TPG seeks to invest in products, technologies, and services that are improving patient access and outcomes while promoting efficiency and innovation across the system.
For over two decades, Surescripts has provided healthcare with simpler, trusted health intelligence sharing. Surescripts E-Prescribing first transformed healthcare by bringing secure, accurate prescriptions that enhance patient safety. Since then, Surescripts has advanced health intelligence sharing, supporting nearly 24 billion exchanges of patient clinical and benefit information in 2023, providing better informed, safer and less costly care for patients nationwide.
The deal is subject to customary regulatory approvals.
TripleTree served as the exclusive financial advisor to Surescripts for this transaction. Cleary Gottlieb Steen & Hamilton served as legal counsel for Surescripts. Evercore, J.P. Morgan Securities and Deutsche Bank acted as financial advisors to TPG, and Kirkland & Ellis served as legal counsel.
KEY QUOTES:
“Surescripts is uniquely poised to address the numerous challenges facing healthcare today and help healthcare heal itself. We are partnering with TPG because of our shared vision for improving healthcare for patients and the clinicians who care for them. TPG’s support will enable us to scale existing solutions while advancing new innovative technologies that will continue to enhance patient safety, lower costs and ensure quality care, amplifying our impact across healthcare.”
- Frank Harvey, Chief Executive Officer for Surescripts
“We have long admired Surescripts for its central role in revolutionizing how clinicians care for their patients, and we recognize the potential that exists to continue transforming health intelligence sharing and patient care.”
- Katherine Wood and Art Heidrich, Partners at TPG
“TPG and Surescripts share similar priorities focused on meeting the needs and addressing the challenges facing clinicians and patients across healthcare in the U.S. Together, we can deliver impact at scale, improving quality and patient outcomes.”
- John Schilling, M.D., Co-Managing Partner of TPG Capital
